Download PDF
Thromb Haemost 1975; 34(03): 855-858
DOI: 10.1055/s-0038-1651373
Letter to the Editor
Schattauer GmbH

Continuous Thrombin Irrigation for Abscessed Hematoma in Hemophiliac with Factor VIII Inhibitor

Bruce M Wimer
Further Information

Publication History

Publication Date:
02 July 2018 (online)

    Permissions and Reprints

 

 

  • References

  • 1 Abildgaard C. F, Britton M, and Roberts R. 1974; Prothrombin complex concentrate (Konyne) for patients with factor VIII inhibitors. Blood 44: 933.
    PubMedGoogle Scholar
  • 2 Blatt P. M, Lundblad R. L, Kingdon H. S, McLean G, and Roberts H. R. 1974; Thrombogenic materials in prothrombin complex concentrates. Annals of Internal Medicine 81: 766.
    CrossrefPubMedGoogle Scholar
  • 3 Deykin D. 1974; Factor VIII inhibitors (Editorial). New England Journal of Medicine 291: 205.
    CrossrefPubMedGoogle Scholar
  • 4 Girolami A, Cliffton E. E, and Agostino D. 1966; Hemorrhagic syndrome in dogs induced by intravenous thrombin. Thrombosis et Diathesis Haemorrhagica 16: 243.
    PubMedGoogle Scholar
  • 5 Hoie J, and Schenk Jr. W. G. 1972; Hemodynamics of disseminated intravascular coagulation. Archives of Surgery 104: 838.
    CrossrefPubMedGoogle Scholar
  • 6 Kurczynski E. M, and Penner J. A. 1974; Activated prothrombin concentrate for patients with factor VIII inhibitors. New England Journal of Medicine 291: 164.
    CrossrefPubMedGoogle Scholar
  • 7 Leandoee L, and Nilehn J.-E. 1969; Effect of intravenous injection of stypven or thrombin on coagulation and fibrinolysis of blood and lymph in dogs. Acta Chirurgica Scandinavica 135: 7.
    PubMedGoogle Scholar
  • 8 Olsson P, Swedenborg J, and Teger-Nilsson A.-C. 1969; Thrombin-induced vasodilatation and hypotension in dogs : Role of fibrinogen, plasma kinins, and blood cells. Cardiovascular Research 3: 56.
    CrossrefPubMedGoogle Scholar
  • 9 Putnam T. J. 1943; The use of thrombin on soluble cellulose in neurosurgery. Annals of Surgery 118: 127.
    CrossrefPubMedGoogle Scholar
  • 10 Seegers W. H, Warner E. D, Brinkhous K. M, and Smith H. P. 1939; The use of purified thrombin as a hemostatic agent. Science 89: 86.
    PubMedGoogle Scholar
  • 11 Sultan Y, Brouet J. C, and Debre P. 1974; Treatment of inhibitors to factor VIII with activated prothrombin concentrate. New England Journal of Medicine 291: 1087.
    PubMedGoogle Scholar
  • 12 Stallings J. O, and Wilson M. H. 1971; Another way to manage the split-thickness skin donor site. Journal of Bone and Joint Surgery 53A: 185.
    PubMedGoogle Scholar
  • 13 Tagnon H. J. 1945; The nature of the mechanism of the shock produced by the injection of trypsin and thrombin. Journal of Clinical Investigation 24: 1.
    CrossrefPubMedGoogle Scholar
  • 14 Tidrick R. T, Seegers W. H, and Warner E. D. 1943; Clinical experience with thrombin as a hemostatic agent. Surgery 14: 191.
    PubMedGoogle Scholar
  • 15 Tishkoff G. H. 1975; Prothrombin complex to treat factor VIII inhibition. (Correspondence). New England Journal of Medicine 292: 754.
    PubMedGoogle Scholar
  • 16 Warner E. D, Brinkhous K. M, Seegers W. H, and Smith H. P. 1939; Further experience with the use of thrombin as a hemostatic agent. Proceedings of the Society for Experimental Biology and Medicine 41: 655.
    PubMedGoogle Scholar
  • 17 Whitaker A. N, and McKay D. G. 1969; Induction of hypotension in Rhesus monkeys and rabbits by intravenous thrombin infusion. Laboratory Investigation 20: 79.
    PubMedGoogle Scholar